Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study-Reference-Cited by-同舟云学术

Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study

Published:2017-12-01 Issue:2 Volume:81 Page:269-275
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Shien Tadahiko^ORCID,Doihara Hiroyoshi,Sato Nobuaki,Anan Keisei,Komaki Kansei,Miyauchi Keisuke,Yanagita Yasuhiro,Fujisawa Tomomi,Mitsuyama Shoshu,Kanbayashi Chizuko,Kusama Mikihiro,Kimura Morihiko,Jinno Hiromitsu,Sano Muneaki,Ikeda Tadashi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3491-6/fulltext.html

Reference25 articles.

1. Holli K, Valavaara R, Blanco G et al (2000) Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer. Finnish Breast Cancer Group. J Clin Oncol 8(20):3487–3494

2. Pagani O, Gelber S, Price K et al (2004) Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12–93 and 14–93. Ann Oncol 15(12):1749–1759

3. Harvey HA, Kimura M, Hajba A (2006) Toremifene: an evaluation of its safety profile. Breast 15(2):142–57

4. Coates AS, Keshaviah A, Thürlimann B et al (2007) Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1–98. J Clin Oncol 25(5):486–92

5. Kusama M, Miyauchi K, Aoyama H et al (2004) Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer. Breast Cancer Res Treat 88(1):1–8

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study;Lipids in Health and Disease;2024-01-08

2. Relationship between family support, serum lipid knowledge and quality of life in Chinese breast cancer women with adjuvant endocrine therapy;Supportive Care in Cancer;2022-11-09

3. Comparison of dyslipidemia incidence in Chinese early-stage breast cancer patients following different endocrine therapies: A population-based cohort study;Frontiers in Endocrinology;2022-09-06

4. The effect of tamoxifen on the lipid profile in women: A systematic review and meta-analysis of randomized controlled trials;Experimental Gerontology;2022-03

5. Lipid Changes During Endocrine Therapy in Breast Cancer Patients: The Results of a 5-Year Real-World Retrospective Analysis;Frontiers in Oncology;2022-01-17